In a healthy individual, the immune system responds to “foreign” cells (such as cancer) by attacking and eliminating them. Unfortunately, […]
Tak Mak is a world leader in the genetics of immunology and cancer. He is currently a Senior Scientist at […]
Introduction The first publication of cancer genome sequencing was in 2006, whereby more than 13,000 genes involved in breast and […]
A preclinical study has provided in vitro and in vivo evidence for using mutated KRAS epitopes as a viable target […]
A recent review, published in Cancers, has summarised the current landscape of ctDNA analysis in clinical practice as well as […]
The international neoantigen initiative Tumour Neoantigen Selection Alliance (TESLA) has identified key parameters for immunotherapy advancement. Neoantigens Somatic alterations are […]
Researchers from Barts Cancer Institute and The Institute of Cancer Research (ICR) London have developed a computational model that maps […]
